FAES FARMA is a Spanish pharmaceutical company with a global presence, primarily engaged in the research, development, manufacturing, and marketing of prescription medicines, healthcare products, and animal nutrition products. Founded in 1933, it is a public company listed on the Spanish stock exchanges.

The company is organized into two main business areas:

Pharma & Healthcare:
This division focuses on human health products, including prescription and over-the-counter (OTC) medicines, food supplements, personal care treatments, and active pharmaceutical ingredients (APIs).

FARM Faes:
This area specializes in high-quality nutritional solutions and strategies for animal health and well-being, covering livestock like pigs, ruminants, poultry, and aquaculture.
Key Therapeutic Areas & Products

FAES FARMA’s research and development (R&D) strategy centers on creating innovative solutions in several therapeutic areas, notably allergy, ophthalmology, gastrointestinal diseases, and bone health. Key proprietary molecules include:

Bilastine:
A leading antihistamine molecule for treating allergies, licensed in over 130 countries worldwide.

Calcifediol:
An active ingredient used for the treatment of Vitamin D deficiency.

Mesalazine:
Effective against inflammation caused by inflammatory bowel diseases, such as ulcerative colitis.

International Presence
Headquartered in Leioa, Spain, FAES FARMA has expanded into an international group with a presence across five continents and products marketed in over 130 countries. It operates through various subsidiaries in countries including Portugal, Italy, Mexico, Colombia, Chile, Peru, Guatemala, and Nigeria.